The evolution of HLA-B*3501 binding affinity to variable immunodominant NP(418-426) peptides from 1918 to 2009 pandemic influenza A virus: a molecular dynamics simulation and free energy calculation study

Chem Biol Drug Des. 2012 Jun;79(6):1025-32. doi: 10.1111/j.1747-0285.2012.01357.x. Epub 2012 Mar 19.

Abstract

Virus-specific cytotoxic T lymphocytes contribute to the control of virus infections including those caused by influenza viruses. However, during the evolution of influenza A viruses, variations in cytotoxic T lymphocytes epitopes have been observed and it will affect the recognition by virus-specific cytotoxic T lymphocytes and the human virus-specific cytotoxic T lymphocytes response in vitro. Here, to gain further insights into the molecular mechanism of the virus-specific cytotoxic T lymphocytes immunity, the class I major histocompatibility complex-encoded HLA-B*3501 protein with six different NP(418-426) antigenic peptides emerging from 1918 to 2009 pandemic influenza A virus were studied by molecular dynamics simulation. Dynamical and structural properties (such as atomic fluctuations, solvent-accessible surface areas, binding free energy), based on the solvated protein-peptide complexes, were compared. Free energy calculations emphasized the important role of the secondary anchors (positions 2 and 9) in influencing the binding of MHC-I with antigenic non-apeptides. Furthermore, major interactions with peptides were gained from HLA-B*3501 residues: Tyr7, Ile66, Lys146, Trp147, and Tyr159. Detailed analysis could help to understand how different NP(418-426) mutants effectively bind with the HLA-B*3501.

Publication types

  • Historical Article
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Sequence
  • Binding Sites
  • Evolution, Molecular
  • HLA-B35 Antigen / metabolism*
  • History, 20th Century
  • History, 21st Century
  • Humans
  • Hydrogen Bonding
  • Influenza A virus / metabolism*
  • Influenza, Human / epidemiology
  • Influenza, Human / history
  • Molecular Dynamics Simulation*
  • Mutation
  • Nucleoproteins / genetics
  • Nucleoproteins / immunology
  • Nucleoproteins / metabolism*
  • Pandemics
  • Protein Binding
  • Protein Structure, Tertiary
  • T-Lymphocytes, Cytotoxic / immunology
  • Thermodynamics

Substances

  • HLA-B*35:01 antigen
  • HLA-B35 Antigen
  • Nucleoproteins